Published May 22, 2003
| Version v1
Patent
Open
N4 virion single-stranded DNA dependent RNA polymerase
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
A histidine-tagged, deletion mutant of bacteriophage N4-coded, virion RNA polymerase (mini-vRNAP) which is active has been developed. The his-tagged mini-vRNAP has been cloned under the control of the pBAD promoter, is stable and is purified in a single step yielding large amounts (10 mg/liter of E. coli expressing cells). This RNA polymerase uses single-stranded DNA containing 17 bases (the promoter) upstream of the transcribed regions as a template. In the presence of E. coli SSB protein, it transcribes this template efficiently, providing a unique system to synthesize RNAs of the desired sequence using single-stranded DNA templates. The enzyme incorporates derivatized nucleoside triphosphates with high efficiency. A mutant of mini-vRNAP has been generated that incorporates deoxynucleoside triphosphates. In addition, the inventors have developed an in vivo system to express RNAs and proteins under mini vRNA polymerase promoter control.
Files
US7452705.pdf
Files
(3.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:21eec02a5bdf312d5939037cd65d6086
|
3.9 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 15321902 A
- Patent application number
- US 2003/0096349 A1
- Other
- oai:uchicago.tind.io:8965
Dates
- Patent filed
-
2002-05-22